A prospective study of measurement of circulating tumor DNA during neoadjuvant chemotherapy for esophageal cancer

A prospective study of measurement of circulating tumor DNA during neoadjuvant chemotherapy for esophageal cancer - A prospective study of measurement of circulating tumor DNA during neoadjuvant chemotherapy for esophageal cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029788

Enrollment

Registered

2017-11-01

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

resectable advanced esophageal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients are planned to undergo neoadjuvant chemotherapy and subsequent surgery for resectable advanced esophageal cancer.

Exclusion criteria

Exclusion criteria: The patients follow our protocol.

Design outcomes

Primary

Measure	Time frame
The correlation of the amount of circulating tumor DNA before and after neoadjuvant chemotherapy and the relapse-free survival	—

Countries

Japan

Contacts

Public ContactToshiaki Tsuji

Wakayama medical university 2nd department of surgery

totsuji@wakayama-med.ac.jp073-441-0613

Outcome results